This trial is testing whether adding pacing to both ventricles is of benefit in heart failure patients with a permanent irregular heart rhythm (atrial fibrillation).
1 Primary · 8 Secondary · Reporting Duration: Baseline to a minimum of 18 months
200 Total Participants · 2 Treatment Groups
Primary Treatment: Optimal Medical therapy plus ICD · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: